Finex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 8.00 M
as on 10-12-2024
- Revenue 14.83%
(FY 2020)
- Profit -134.59%
(FY 2020)
- Ebitda -74.77%
(FY 2020)
- Net Worth -2.55%
(FY 2020)
- Total Assets -43.69%
(FY 2020)
About Finex Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹8.00 M.
Monita Sinha and Sat Garg serve as directors at the Company.
- CIN/LLPIN
U74900PB2009PTC032674
- Company No.
032674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Sangrur, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Finex Healthcare Private Limited offer?
Finex Healthcare Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Antacid Drugs, Fungal Diastase Pepsin Syrup, Vitamin & Multivitamin Injections, Methylcobalamin Injection, Eye Drops, Moxifloxacin Eye Drop, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Finex Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monita Sinha  | Director | 12-Mar-2009 | Current |
| Sat Garg | Director | 12-Mar-2009 | Current |
Financial Performance of Finex Healthcare.
Finex Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.83% increase. The company also saw a substantial fall in profitability, with a 134.59% decrease in profit. The company's net worth dipped by a decrease of 2.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finex Healthcare?
In 2021, Finex Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 20 May 2013 | ₹6.00 M | Open |
State Bank Of Patiala Creation Date: 13 Mar 2012 | ₹2.00 M | Open |
How Many Employees Work at Finex Healthcare?
Unlock and access historical data on people associated with Finex Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Finex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
